Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Moers – page 2

19 clinical trials in Moers, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Moers at a glance
19
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

19 trials in Moers

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ceralasertib
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Domvanalimab
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Samsung Bioepis Co. Ltd.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Hydroxycarbamide
  • Sponsor:Novartis Pharma GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Moers

What the registry says about research in the country

01 Lung Cancer Research

Innovative clinical trials focusing on non-small cell lung cancer (NSCLC) treatment approaches, particularly exploring combination therapies with targeted agents and immunotherapy.

  • Advanced and Metastatic NSCLC
  • Stage IIB-IIIB Resectable NSCLC
  • Mutation-Specific Treatments

Multiple studies evaluating novel drug combinations with pembrolizumab and other immunotherapy agents to improve patient outcomes.

02 Respiratory Medicine

Research focusing on chronic respiratory conditions, with particular emphasis on Chronic Obstructive Pulmonary Disease (COPD) management and treatment optimization.

  • Triple Therapy Evaluation
  • Cardiopulmonary Outcomes
  • Bronchodilator Combinations

Studies examining innovative inhaler combinations to improve respiratory function and patient quality of life.

03 Gastrointestinal Oncology

Clinical research investigating treatments for advanced gastric cancer and gastroesophageal junction adenocarcinoma, with focus on protein-targeted therapies.

  • Targeted Protein Therapies
  • Advanced/Metastatic Disease
  • Comparative Treatment Studies

Innovative approaches examining novel compounds against standard cancer treatments for specific patient populations.

04 Hematologic Disorders

Research initiatives exploring treatment resistance in polycythemia vera, utilizing artificial intelligence to predict treatment outcomes.

  • Hydroxyurea Resistance
  • AI-Based Predictions
  • Treatment Response Analysis

Integration of machine learning approaches to optimize treatment strategies for blood disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.